Jubilant Pharmova Ltd 2008 SR
The report highlights Jubilant Organosys Limited's integration of sustainability into its pharmaceutical and life sciences business. Key achievements include a 37.5% revenue growth and the acquisition of Hollister-Stier Laboratories. The company achieved an 8% reduction in water consumption at its Gajraula plant and implemented several energy conservation projects. Social initiatives focused on primary education through the Muskaan project and healthcare, including a workplace HIV/AIDS prevention program in partnership with the ILO. The report follows GRI G3 guidelines with an A+ application level and includes external assurance.
Company: Jubilant Pharmova Ltd
Sector: Manufacturing
Country: India
Year: 2008
Type: SR
Pages: 64
Back to company
Jubilant Pharmova Ltd
Corporate Sustainability Report
The report highlights Jubilant Organosys Limited's integration of sustainability into its pharmaceutical and life sciences business. Key achievements include a 37.5% revenue growth and the acquisition of Hollister-Stier Laboratories. The company achieved an 8% reduction in water consumption at its Gajraula plant and implemented several energy conservation projects. Social initiatives focused on primary education through the Muskaan project and healthcare, including a workplace HIV/AIDS prevention program in partnership with the ILO. The report follows GRI G3 guidelines with an A+ application level and includes external assurance.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2008
Reporting Period
Apr 1, 2007 - Mar 31, 2008
Fiscal Year
2008
Published
Aug 21, 2008
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Workplace Fatalities
Employees